Weight-loss drug

Novo Nordisk Cuts Off Hims & Hers Over Wegovy Dispute, Putting a Spotlight on Telehealth’s Regulatory Edge

Novo Nordisk abruptly ended its partnership with Hims & Hers, citing the illegal distribution of compounded Wegovy alternatives. The fallout…

Read More »